- Speculative company that produces ‘bionic eyes.’
- It has multiple growth avenues in front of it and much of the hard work is already behind them.
- However, for investors there remain considerable financial risks.
Source: First Look At Second Sight – Second Sight Medical Products (NASDAQ:EYES) | Seeking Alpha